Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)
Clinical trial NCT01570868 · TERMINATED
Trial details
- NCT number
- NCT01570868
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.